UPDATE 1-Mylan wins round in fight with Teva over multiple sclerosis drug

UPDATE 1-Mylan wins round in fight with Teva over multiple sclerosis drug


Aug 24 Pharmaceutical company Mylan NV has won a round in its fight with Teva Pharmaceutical Industries Ltd at the U.S. Patent and Trademark Office, which said on Wednesday that two patents for the multiple sclerosis drug Copaxone sold by Teva were, after a review process, considered unpatentable. The USPTO did not immediately have a decision on a third patent for Copaxone that it is also considering reviewing.



from Biotech News